Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels

Status:
COMPLETED

Trial end date:
2024-08-31

Target enrollment:

Participant gender:

Particpants were divided into groups based on doses of rosuvastatin and were assessed and for CPK, LDL and AST levels

Central Park Medical College

Rosuvastatin Calcium